CRDL
Cardiol Therapeutics
CRDL
CRDL
32 hedge funds and large institutions have $6.02M invested in Cardiol Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% less funds holding
Funds holding: 35 → 32 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
32
Holding in Top 10
–
Calls
$45K
Puts
$2K
Top Buyers
| 1 | +$397K | |
| 2 | +$161K | |
| 3 | +$33K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$9.4K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$2.92K |
Top Sellers
| 1 | -$63K | |
| 2 | -$30K | |
| 3 | -$13.3K | |
| 4 |
MA
MONECO Advisors
Fairfield,
Connecticut
|
-$12.5K |
| 5 |
HF
HRT Financial
New York
|
-$11K |